Literature DB >> 15350033

Imaging of sacral tumors.

Betty Jean Manaster1, Travis Graham.   

Abstract

Sacral tumors are somewhat unique to the skeletal system in that the prevalence of various neoplasms is different from that at other osseous sites. There are also unique imaging-related considerations, related in part to diagnosis, but particularly to the evaluation site for tumor biopsy sampling and resection. In this report, the authors describe imaging features of the most common sacral lesions, provide numerous radiological examples, and give suggestions for optimal imaging of this region of the body.

Entities:  

Mesh:

Year:  2003        PMID: 15350033     DOI: 10.3171/foc.2003.15.2.2

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  5 in total

Review 1.  Imaging features of primary and secondary malignant tumours of the sacrum.

Authors:  E Thornton; K M Krajewski; K N O'Regan; A A Giardino; J P Jagannathan; N Ramaiya
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Giuseppe Ussia; Andrea Angelini; Panayiotis J Papagelopoulos; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 3.  Imaging of sacral tumours.

Authors:  S Gerber; L Ollivier; J Leclère; D Vanel; G Missenard; H Brisse; G de Pinieux; S Neuenschwander
Journal:  Skeletal Radiol       Date:  2007-11-23       Impact factor: 2.199

Review 4.  Clinical manifestations, classification, and surgical management of sacral tumors and the need for personalized approach to sacrectomy.

Authors:  Brian Fiani; Juliana Runnels; Alexander Rose; Athanasios Kondilis; Amelia Wong; Brian L Musch
Journal:  Surg Neurol Int       Date:  2021-05-03

5.  Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum.

Authors:  Shinji Tsukamoto; Nikolin Ali; Andreas F Mavrogenis; Kanya Honoki; Yasuhito Tanaka; Paolo Spinnato; Davide Maria Donati; Costantino Errani
Journal:  BMC Musculoskelet Disord       Date:  2021-12-06       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.